Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells

British Journal of Haematology
Renée BazinIsabelle St-Amour

Abstract

Intravenous immunoglobulins (IVIg) have immunomodulatory effects in vivo and are widely used in the treatment of autoimmune diseases, such as idiopathic thrombocytopenic purpura (ITP). The mechanisms by which IVIg can prevent platelet clearance in ITP patients are not fully understood but are known to require the participation of low affinity Fcgamma receptors (FcgammaRs), which interact poorly with monomeric immunoglobulin G (IgG). Given the importance of low affinity FcgammaRs in the treatment of ITP, we hypothesized that immune complexes (IC) produced in vitro could reproduce the effects of IVIg. Small-size tetramolecular IC were prepared using mouse monoclonal anti-human IgG and human Fc fragments. The effects of tetramolecular IC and IVIg on the in vitro and in vivo inhibition of phagocytosis of opsonized blood cells were compared. The results obtained showed that tetramolecular IC were at least six times more efficient than IVIg to prevent phagocytosis of opsonized red blood cells in vitro, and clearance of platelets in the thrombocytopenic mouse model.

References

Oct 1, 1990·Journal of Bioluminescence and Chemiluminescence·I DowningR H Fraser
May 8, 1986·The New England Journal of Medicine·S B ClarksonJ C Unkeless
Sep 13, 1988·Journal of Immunological Methods·T E Thomas, P M Lansdorp
Jun 1, 1986·European Journal of Immunology·P M LansdorpE F Van Bruggen
Aug 1, 1993·Molecular Immunology·S Avrameas, T Ternynck
Jan 1, 1997·Annual Review of Immunology·M Daëron
Jul 9, 1999·Biotechnology and Bioengineering·H KhoudiL P Vézina
Feb 17, 2000·Seminars in Hematology·R McMillan
Oct 6, 2000·Science·J V Ravetch, L L Lanier
Aug 30, 2001·Trends in Immunology·H M DijstelbloemC G Kallenberg
Sep 8, 2001·The New England Journal of Medicine·M D Kazatchkine, S V Kaveri
Sep 26, 2003·Transfusion·Irina Knezevic-Maramica, Margot S Kruskall

❮ Previous
Next ❯

Citations

May 4, 2005·Human Immunology·Feng Jin, Joseph P Balthasar
Aug 26, 2010·The Journal of Biological Chemistry·Christine Y Zhang, James W Booth
Oct 18, 2008·Trends in Immunology·Thanyalak Tha-InJaap Kwekkeboom
Jun 21, 2013·Journal of the Peripheral Nervous System : JPNS·Marzieh NiknamiJohn D Pollard
Feb 7, 2012·Biochemical and Biophysical Research Communications·Yusuke MachinoYasuhiko Masuho
Jan 5, 2005·The Journal of Clinical Investigation·Raphael Clynes
Jan 7, 2014·Journal of Autoimmunity·Muthusamy ThiruppathiMatthew N Meriggioli
Jun 14, 2014·MAbs·Austin W BoeschMargaret E Ackerman
Jan 28, 2014·Biochemistry. Biokhimii︠a︡·M A SedykhG A Nevinsky
Feb 7, 2013·Transfusion·Donald R Branch
Nov 20, 2016·Science Translational Medicine·Daniel F OrtizCarlos J Bosques
Dec 24, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiaoyu ZhangScott E Strome

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.